Skip to main content
Clinical Trials/PACTR201911571076749
PACTR201911571076749
Completed
Phase 1

The perioperative outcome of inhaled and intravenous levosimendan in children with pulmonary hypertension undergoing on pump cardiac surgery: a comparative randomized study

Mansoura university children hospital0 sites60 target enrollmentNovember 9, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Paediatrics
Sponsor
Mansoura university children hospital
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 9, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mansoura university children hospital

Eligibility Criteria

Inclusion Criteria

  • 1\-Age from 1 to 10 years
  • 2\-on pump elective correction of congenital heart diseases
  • 3\- pulmonary arterial hypertension

Exclusion Criteria

  • 1\-refusal of the patients guardians
  • 2\- contraindication to use TEE
  • 3\-redo cardiac surgery
  • 4\-coagulation disorders
  • 5\-renal, hepatic or pulmonary disease
  • 6\-heart failure, Eisenmenger syndrome or right to left shunts and hypersensitivity of any of the studied drugs.

Outcomes

Primary Outcomes

Not specified

Similar Trials